Search Result "combi-triazenes"
Molecular Analysis of the In Vivo Metabolism and Biodistribution of Metabolically and Non-Metabolically Activated Combi-Molecules of the Triazene Class
Journal: Drug Metabolism Letters
Volume: 3 Issue: 1 Year: 2009 Page: 1-9
Author(s): Qiyu Qiu, Anne-Laure Larroque, Bernard Gibbs, Youqiang Fang, Younes Lakhrissi, Jean-Paul Soucy, Shadreck Mzengeza, Zakaria Rachid, Bertrand J. Jean-Claude
Anticancer Triazenes: from Bioprecursors to Hybrid Molecules
Journal: Current Pharmaceutical Design
Volume: 25 Issue: 14 Year: 2019 Page: 1623-1642
Author(s): Ana P. Francisco,Eduarda Mendes,Ana R. Santos,Maria J. Perry
In Vitro and In Vivo Biodistribution of ZRS1, a Stabilized Type I N-Acetoxymethyl Carbamate-Containing Combi-Molecule
Journal: Drug Metabolism Letters
Volume: 5 Issue: 2 Year: 2011 Page: 141-149
Author(s): Nahid Golabi, Zakaria Rachid, Qiyu Qiu, Ying Huang, Bertrand J. Jean-Claude
Exploration of Chemical Space Based on 4-Anilinoquinazoline
Journal: Current Medicinal Chemistry
Volume: 19 Issue: 6 Year: 2012 Page: 871-892
Author(s): D.-D. Li, Y.-P. Hou, W. Wang, H.-L. Zhu
Strategies on the Development of Small Molecule Anticancer Drugs for Targeted Therapy
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 11 Issue: 7 Year: 2011 Page: 611-624
Author(s): Y.-H. Lu, X.-Q. Gao, M. Wu, D. Zhang-Negrerie, Q. Gao
Epidermal Growth Factor Receptor as a Target for Anti-Cancer Agent Design
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 10 Issue: 6 Year: 2010 Page: 491-503
Author(s): Jiangying Cao, Hao Fang, Binghe Wang, Chunhua Ma, Wenfang Xu
Tyrosine Kinase Blockers: New Hope for Successful Cancer Therapy
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 9 Issue: 1 Year: 2009 Page: 66-76
Author(s): Dariusz Pytel, Tomasz Sliwinski, Tomasz Poplawski, Deborah Ferriola, Ireneusz Majsterek
Ellipticine, its Derivatives: Re-evaluation of Clinical Suitability with the Aid of Drug Delivery Systems
Journal: Current Cancer Drug Targets
Volume: 20 Issue: 1 Year: 2020 Page: 33-46
Author(s): Vipin Mohan Dan,Thania Sara Varghese,Gayathri Viswanathan,Sabulal Baby
Overcoming Resistance of Glioblastoma to Conventional Cytotoxic Therapies by the Addition of PARP Inhibitors
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 10 Issue: 7 Year: 2010 Page: 520-533
Author(s): Anthony J. Chalmers
Dihydrofolate Reductase as a Target for Chemotherapy in Parasites
Journal: Current Pharmaceutical Design
Volume: 13 Issue: 6 Year: 2007 Page: 609-639
Author(s): A. Gangjee, S. Kurup, O. Namjoshi